Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Arthur Butowski, David Dinh Tran et al. · The Lancet Oncology · 2017

Cited by 1,134 works. doi:10.1016/s1470-2045(17)30517-x Open-access PDF

Authors

References